WFG Advisors’s Amedisys AMED Stock Holding History

WFG Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-100	Closed	-$2K	–	2218
2013 Q3	$2K	Hold	100	–	–	﹤0.01%	1914
2013 Q2	$1K	Buy	+100	New	+$1.15K	﹤0.01%	1922

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WFG Advisors's AMED Position: Q4 2013 in Review

WFG Advisors sold out of Amedisys (AMED) in Q4 2013, closing a stake of 100 shares — an estimated $2K sold.

WFG Advisors first reported a position in AMED in Q2 2013 and held it in 2 quarters. The position peaked at $2K in Q3 2013. 124 funds tracked by Wall St. Rank hold AMED as of Q4 2013.

WFG Advisors reported no remaining Amedisys position as of Q4 2013 after selling out during the quarter.
WFG Advisors sold 100 Amedisys shares in Q4 2013, an estimated $2K.
WFG Advisors first reported a position in Amedisys in Q2 2013 and held it in 2 quarters.
WFG Advisors's Amedisys position peaked at $2K in Q3 2013.
124 funds tracked by Wall St. Rank held Amedisys as of Q4 2013.

Based on WFG Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.